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Abstract
Genome-wide association studies (GWAS) have identified multiple common variants associated with body mass index (BMI).
In this study, we tested 23 genotyped GWAS-significant SNPs (p-value,5*10-8) for longitudinal associations with BMI
during childhood (3–17 years) and adulthood (18–45 years) for 658 subjects. We also proposed a heuristic forward search for
the best joint effect model to explain the longitudinal BMI variation. After using false discovery rate (FDR) to adjust for
multiple tests, childhood and adulthood BMI were found to be significantly associated with six SNPs each (q-value,0.05),
with one SNP associated with both BMI measurements: KCTD15 rs29941 (q-value,7.6*10-4). These 12 SNPs are located at or
near genes either expressed in the brain (BDNF, KCTD15, TMEM18, MTCH2, and FTO) or implicated in cell apoptosis and
proliferation (FAIM2, MAP2K5, and TFAP2B). The longitudinal effects of FAIM2 rs7138803 on childhood BMI and MAP2K5
rs2241423 on adulthood BMI decreased as age increased (q-value,0.05). The FTO candidate SNPs, rs6499640 at the 5 9-end
and rs1121980 and rs8050136 downstream, were associated with childhood and adulthood BMI, respectively, and the risk
effects of rs6499640 and rs1121980 increased as birth weight decreased. The best joint effect model for childhood and
adulthood BMI contained 14 and 15 SNPs each, with 11 in common, and the percentage of explained variance increased
from 0.17% and 9.0*10
26% to 2.22% and 2.71%, respectively. In summary, this study evidenced the presence of long-term
major effects of genes on obesity development, implicated in pathways related to neural development and cell metabolism,
and different sets of genes associated with childhood and adulthood BMI, respectively. The gene effects can vary with age
and be modified by prenatal development. The best joint effect model indicated that multiple variants with effects that are
weak or absent alone can nevertheless jointly exert a large longitudinal effect on BMI.
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Introduction
Obesity, a major global public health concern, is a deleterious
factor associated with different diseases, including cardiovascular
events, type 2 diabetes mellitus, sleep -breathing abnormalities,
and some cancers [1,2]. The prevalence of obesity in children and
adults has increased strikingly over the past decades, leading to an
increased likelihood of serious obesity-related complications and
decreased life expectancy [3]. Thus, reducing obesity prevalence
in adults and preventing overweight from early childhood is of
great importance in terms of public health.
The predisposition to obesity varies widely in the population
and is partially genetically determined. Intrauterine growth, mea-
sured by birth weight, can influence the probability of suffering
from obesity in future life [4,5]. Heritability of the underlying
genetic components ranges from 25% to 40% according to family
studies, and from 50% to 80% according to twin studies.
Longitudinal studies in twins have shown genetic effects on
obesity through middle age (over the course of 43 years) [6].
Recent advances in genome-wide association studies (GWAS) have
evidenced the association of common variants of several different
genes with body mass index. Among these genes, FTO has been
repeatedly identified [7–11], and KCTD15, TMEM18, MTCH2,
and NEGR1 have been considered to confer obesity risk through
effects in the central nervous system [9]. Novel functions of three
other genes, FAIM2, MAP2K5, and TFAP2B, were also found to
be associated with obesity development [11].
The longitudinal effects of these GWAS findings over the course
of childhood and adulthood, however, have not been widely
studied, and each variant can explain only a very small proportion
of BMI variance. It is not yet clear if there are joint effects among
these variants and if these effects are age-dependent and modifiable
by birth weight. To address these questions, we conducted a
longitudinal replication study in the Bogalusa Heart Study cohort,
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Mei        using BMI data collected from 1973 to the present. We previously
identified the longitudinal effects of FTO tag variants associated
with birth weight [12]. In this follow-up study, we will examine 23
additional GWAS-significant SNPs and explore their joint effects
using a heuristic forward searching strategy.
Materials and Methods
The Bogalusa Heart Study is a community-based study of the
natural history of cardiovascular disease since childhood in the
community of Bogalusa, Louisiana. The study is longitudinal, and
the initial cross-sectional study began in 1973–1974. Subsequent
cross-sectional surveys were conducted every 3–4 years during
childhood and young adulthood. At present, seven major cross-
sectional surveys of children aged 3–17 years and six of adults aged
18–44 years, who were previously examined as children, have
been conducted. This enabled us to study the evolution of obesity
over a 40-year lifespan from childhood through middle-age.
Information on personal health and medication history was
obtained from participants through questionnaires. Standard
protocols approved by the Institutional Review Board of the
Tulane University Health Sciences Center were used for the
collection of all data [13,14]. Written informed consent was
obtained from the participants, or their parents (guardians) if the
participants were children.
Participating subjects taken from the BHS for this replication study
consist of 658 whites (308 males and 350 females). The birth weight
data (kg) and gestational age (weeks) from menstrual history were
retrieved from Louisiana State birth certificates. Their anthropomet-
ric measures were made in both childhood and adulthood. All
examinations followed essentially the same protocols. Height and
weightweremeasuredtwiceto 60.1 cm andto 60.1 kg,respectively.
The means of two independent measurements for height (in
centimeters) and weight (in kilograms) were used to calculate BMI
(kilograms per meter squared) as the measure of obesity. On average,
study subjects were surveyed 4.3 times over childhood and 4.5 times
over adulthood. Genotyping of BHS participants was based on the
Illumina Human610 BeadChip and HumanCVD BeadChip (also
referred to as IBC array), and completed in the laboratory of
Genomic Medicine at the Scripps Research Institute in La Jolla,
California [15]. Total 23 SNPs previously reported to be significantly
associated with BMI in GWAS (p-value#5*10
28) were selected for
this replicated longitudinal study, based on PubMed literature review
and NHGRI GWAS Catalog [16,17].
Statistical analyses were performed using R (version 2.10.1).
Linear modeling was used to examine the major effect of each
polymorphism on birth weight, with gestational age and sex
controlled as confounding covariates. Longitudinal effects of
candidate SNPs on childhood (age,18 years) and adulthood
(age$18 years) BMI were examined by linear mixed model using
the R package lme4, with birth weight and age as confounding
covariates. A random effect of age was included to control for
repeated measures of BMI at different ages. Interaction tests were
conducted to measure the modifications of variant effects by age
and birth weight. For all studies, both general and additive genetic
models were applied, which respectively treat a SNP as a
categorical factor and as a continuous variable coded as 0, 1, or
2 copies of a particular reference allele. The false discovery rate
(FDR) was taken to adjust for multiple tests [18–20]. The FDR q-
value of a variant association was defined as the smaller of two
genetic models and a q-value#0.05 was considered significant.
A heuristic forward search was proposed to identify the best
joint effect model among candidate variants through the addition
of SNPs one by one. At each forward step, the next SNP and its
corresponding reference allele were identified by the criterion that
the number of reference alleles over all added SNPs must have the
minimum modified Akaike Information Criterion (AIC) [21] of the
linear mixed model. The modified AIC is defined as: 2*(the
number of SNPs+the number of non-SNP parameters) – 2*ln(L),
where L is the maximized likelihood for the estimated model. The
search will stop when the modified AIC of the best joint effect
model cannot be further reduced in the next step. The BMI was
permuted 10,000 times to generate distribution of a random best
joint effect model and the empirical p-value was calculated as the
percentage of minimized AIC#observed minimized AIC.
Results
Characteristics of participants at birth, first measurement during
childhood, last measurement during adulthood, and p values for
differences between genders are summarized in Table 1. Descrip-
tions of 23 replicated SNPs are presented in Table 2. Hardy-
Weinberg Equilibrium (HWE) was met for all SNPs in the study
cohort. After adjustment for multiple tests, no significant
associations were observed between candidate SNPs and birth
weight (results not shown).
Logarithm base 10 q-values are presented in Figure 1 for the
association tests between candidate SNPs and longitudinal BMI
adjusted for birth weight, age, and sex. Six SNPs, rs987237
(TFAP2B), rs6265 (BDNF), rs10767664 (BDNF), rs7138803
(FAIM2), rs6499640(FTO), and rs29941 (KCTD15), were associated
with longitudinal childhood BMI with q-values (p-values) of 0.03
(0.004), 0.009 (8.6*10
24), 0.005 (3.7*10
24), 0.03 (0.004), 0.03 (0.004),
and 3.2*10
24 (6.6*10
26), respectively. Six other SNPs, rs2867125
(TMEM18), rs10838738 (MTCH2), rs2241423 (MAP2K5),
rs1121980 (FTO), rs8050136 (FTO), and rs29941 (KCTD15), were
associated with longitudinal adulthood BMI, with q-values (p-values)
of 0.009 (7.5*10
24), 0.04 (0.007), 7.6*10
24 (2.8*10
25), 0.005
(3.8*10
24), 1.8*10
24 (2.5*10
26), and 7.6*10
24 (3.1*10
25), respec-
tively. The FTO regional recombination rate (HapMap rel. 22) [22]
and LD (HapMap rel. 27) for the three candidate FTO-gene SNPs
found in this study are presented in Figure 2.
For each significant SNP, we compared the heterozygous
genotype and the homozygous genotype with the higher BMI to
the homozygous genotype with the lower BMI. The genotypes
(effects) are as follows: for childhood BMI, AG (0.18) and GG
(1.72) for rs987237, AG (1.51) and GG (1.74) for rs6265, TA (1.51)
and AA (1.74) for rs10767664, AG (0.36) and GG (0.72) for
rs7138803, AG (20.53) and GG (0.07) for rs6499640, and CT
(20.57) and TT (0.83) for rs29941; for adulthood BMI, GA
(20.59) and AA (2.17) for rs2867125, AG (0.58) and GG (1.15) for
rs10838738, AG (1.04) and GG (2.08) for rs2241423, CT (20.26)
and TT (1.31) for rs1121980, CA (20.57) and AA (1.56) for
rs8050136, and CT (0.18) and TT (2.37) for rs29941. The results
are illustrated in Figure 3. General inheritance models were best
for all SNPs except rs10838738, rs2241423, and rs7138803, for
which additive inheritance models were best.
The significant interactions of SNP6age and SNP6birth weight
are presented in Table 3. There were significant interactions
between age and rs7138803 (FAIM2) for childhood BMI (q-
value=7.56*10
24, p-value=2.46*10
25) and between age and
rs2241423 (MAP2K5) for adulthood BMI (q-value=0.02, p-
value=0.002) with adjustment for sex and birth weight. Each year
of increase in age is estimated to decrease genotype AG and GG
effects by 0.07 (b1) and 0.17 (b2) for rs7138803, respectively, and
genotype AG and GG by 0.05 (b1) and 0.10 (b2) for rs2241423,
respectively. There were also significant interactions between birth
weight and rs6499640 (FTO) for childhood BMI (q-value=0.037,
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for adulthood BMI (q-value=0.043, p-value=0.009), with
adjustment for age and sex. Each kilogram of increase in birth
weight is estimated to decrease genotype AG and GG effects by
0.91 (b1) and 0.04 (b2) for rs6499640, respectively, and genotype
CT and TT by 0.88 (b1) and 1.75 (b2) for rs1121980, respectively.
The best joint effect model for longitudinal BMI was generated
by sequentially adding SNPs, with adjustment for age, sex, and
birth weight; these results are presented in Figure 4. The best
model for childhood BMI contained 14 SNPs and increasingly
explained the variance, from 0.17% for the first added SNP
(CADM2 rs13078807) to 2.2% for the last added SNP (ETV5
rs7647305). Every additional copy of the reference allele was
estimated to increase BMI by 0.27, with an empirical p-value=0.
The interaction test showed that a one year increase in age
decreased the risk variant effect on BMI by 0.01 (p,0.05). No
significant interaction was observed between the best model and
birth weight. The best model for adulthood BMI contained 15
SNPs and increasingly explained the variance from 9.0*10
26% for
the first added SNP (NEGR1 rs2815752) to 2.7% for the last
added SNP (ETV5 rs7647305). Each copy of the reference allele
was estimated to increase BMI by 0.51, with an empirical p-
value=0. No significant interaction was observed between the best
model and age or between the best model and birth weight
(p.0.05).
Table 1. Mean levels (standard deviation) of study variables
by sex.
Male
(N=308)
Female
(N=350)
Gender*
Difference
Birth Registry Information
Birth weight (kg) 3.47 (0.53) 3.33 (0.52) P,0.001
Gestational Age (week) 39.77 (1.67) 39.81 (1.90) P=0.798
Childhood (first Measurement)
Age (year) 9.92 (3.17) 9.66 (3.18) P=0.303
Weight (kg) 35.21 (15.21) 33.86 (14.26) P=0.532
Height (cm) 137.94 (19.74) 135.55 (19.11) P=0.070
BMI (kg/m
2) 17.64 (3.41) 17.55 (3.45) P=0.890
Adulthood (Last Measurement)
Age (year) 33 (4.67) 32.13 (4.90) P=0.206
Weight (kg) 89.34 (18.19) 72.31 (19.54) P,0.001
Height (cm) 177.67 (6.39) 163.26 (6.23) P,0.001
BMI (kg/m
2) 28.26 (5.44) 27.11 (7.15) P=0.023
*Difference in birth weight was adjusted for gestational age; difference in
weight, height and BMI was adjusted for age.
doi:10.1371/journal.pone.0031470.t001
Table 2. Characteristic of candidate SNPs.
SNP Genes CHR strand Position A1/A2 MAF GWAS_P
Hetero-
zygosity HWE_P
rs2568958 NEGR1 1 + 72537704 G/A 0.38 1.00E-11 0.47 0.6
rs2815752 NEGR1 1 2 72585028 C/T 0.38 2.00E-22 0.47 0.6
rs1514175 TNNI3K 1 2 74764232 T/C 0.4 8.00E-14 0.48 1
rs2867125 TMEM18 2 2 612827 A/G 0.18 3.00E-49 0.3 0.35
rs7561317 TMEM18 2 + 634953 A/G 0.19 4.00E-17 0.3 0.13
rs13078807 CADM2 3 + 85966840 G/A 0.22 4.00E-11 0.35 1
rs7647305 ETV5 3 + 187316984 T/C 0.22 7.00E-11 0.35 0.55
rs13107325 SLC39A8 4 + 103407732 T/C 0.09 2.00E-13 0.16 1
rs987237 TFAP2B 6 + 50911009 G/A 0.17 3.00E-20 0.28 0.54
rs10968576 LRRN6C 9 + 28404339 G/A 0.3 3.00E-13 0.42 0.28
rs925946 BDNF 11 + 27623778 T/G 0.33 9.00E-10 0.44 0.48
rs6265 BDNF 11 2 27636492 A/G 0.19 5.00E-10 0.31 0.5
rs10767664 BDNF 11 + 27682562 T/A 0.2 5.00E-26 0.32 0.59
rs10838738 MTCH2 11 + 47619625 G/A 0.35 5.00E-09 0.46 0.65
rs7138803 FAIM2 12 + 48533735 A/G 0.37 2.00E-17 0.46 0.94
rs2241423 MAP2K5 15 + 65873892 A/G 0.22 1.00E-18 0.34 0.26
rs6499640 FTO 16 + 52327178 G/A 0.39 4.00E-13 0.48 0.19
rs1121980 FTO 16 2 52366748 T/C 0.42 4.00E-08 0.49 0.94
rs8050136 FTO 16 + 52373776 A/C 0.4 1.00E-47 0.48 1
rs571312 MC4R 18 2 55990749 T/G 0.23 6.00E-42 0.35 0.08
rs12970134 MC4R 18 + 56035730 A/G 0.27 1.00E-12 0.4 0.43
rs29941 KCTD15 19 2 39001372 T/C 0.31 7.00E-12 0.42 0.62
rs2287019 QPCTL 19 + 50894012 T/C 0.17 2.00E-16 0.29 0.81
Strand: + (sense strand) and 2 (antisense strand); Position (bp): It is based on coordinates of NCBI B36. A1/A2: Minor Allele/Major Allele; MAF: Minor Allele Frequency;
GWAS_P: previously reported GWAS p-value; HWE_P: The p-value of Hardy-Weinberg Equilibrium test.
doi:10.1371/journal.pone.0031470.t002
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Recent genome-wide association studies have identified several
variants associated with BMI. We previously confirmed that FTO
tag SNPs, including rs9939609, were associated with longitudinal
adulthood BMI [12]. In this study, we extended the test to 23
additional GWAS-significant SNPs that were genotyped in the
Bogalusa Heart Study cohort. BMI was repeatedly measured from
age 3.32 to18 years for childhood, and from 18 to 45.30 years for
adulthood. In contrast to other studies that focus on one measure of
BMI per subject or measures at fixed ages, the repeated measures of
BMI at broadly varied ages should cover moreuseful variation inthe
development of obesity determined by genetic components.
Moreover, although the study sample included only 658 white
subjects, multiple measures of BMI at different ages per subject
increasedthesamplesize ofBMI observationsto2,708for childhood
and 2,844 for adulthood. By applying QUANTO [23] software, we
confirmed that this study has 80% power to detect genetic variant or
interaction effects, explaining 2.3% of the variance of the trait, given
the following conditions: sample size of 658, type I error of 0.002
based on Bonferroni adjustment for 23 variants, and an additive
genetic model. However, the study can detect much smaller variant
or interaction effects than estimated here, because the longitudinal
repeated measures serve to increase the number of observations
about 4-fold, and both additive and general genetic models were
examined, in order to reduce the risk of missing risk variants.
In this study, none of the 23 candidate variants was associated
with birth weight (results now shown). The study observed that
variants near or at certain genes were associated with BMI at
different age ranges. Variants near or at BDNF (rs6265 and
rs10767664), FAIM2 (rs7138803), TFAP2B (rs987237), and FTO
(rs6499640) were associated with childhood BMI. Variants near or
at MAP2K5 (rs2241423), MTCH2 (rs10838738), TMEM18
(rs2867125), and FTO (rs1121980 and rs8050136) were associated
with adulthood BMI. Meanwhile, variants near or at KCTD15
rs29941 were associated with both childhood and adulthood BMI.
Among these genes, BDNF [7,24,25], KCTD15 [9], TMEM18
[7,26], and FTO [7,27] were highly expressed in the central
nervous system, and FAIM2 [28], TFAP2B [29], MAP2K5 [30],
and MTCH2 [9,31] were involved in cell apoptosis and
proliferation. These findings suggested that genes implicated in
pathways related to neural development and cell metabolism can
have long-term effects on obesity development, and that the genes
underlying childhood and adulthood BMI can be different.
FTO, a gene on chromosome 16, is highly expressed in the brain,
and may influence feeding regulation [7]. The associations of FTO
Figure 1. Association of candidate SNPs with repeated measures of body mass index (BMI), adjusted for sex, age, and birth weight.
(A) childhood BMI and (B) adulthood BMI.
doi:10.1371/journal.pone.0031470.g001
GWAS Replication Study of Longitudinal BMI
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from HapMap rel. 22. SNP position is based on NCBI build 36 of the human genome.
doi:10.1371/journal.pone.0031470.g002
Figure 3. Major effects of genotypes for candidate SNPs on repeated measures of (A) childhood BMI and (B) adulthood BMI,
adjusted for age and birth weight.
doi:10.1371/journal.pone.0031470.g003
GWAS Replication Study of Longitudinal BMI
PLoS ONE | www.plosone.org 5 February 2012 | Volume 7 | Issue 2 | e31470variants withBMI havebeen widelyreplicatedindifferent studies.In
this study, we confirmed that the FTO effects were longitudinal,
influencing both childhood and adulthood BMI, repeatedly
measured from 3–48 years of age. The results also indicated that
the effects of FTO on obesity, due to a reduction in sensitivity of the
appetite control system [32], can start from a young age, and can
even be modified during prenatal development. However, no
previousstudyprovided the kind of direct evidenceforan association
between FTO and birth weight that was observed in this study. The
FTO candidate SNPs (rs6499640, rs1121980, and rs8050136) were
located at the 59 end, upstream of the tag SNPs (rs9939609,
rs17820875, and rs860713) that were explored previously [12]
(Figure 2). These findings indicate that different regions of FTO are
involved in childhood and adulthood obesity development; the
upstream variant (rs6499640) was found to influence childhood
BMI, and the downstream variants (rs1121980, rs8050136,
rs9939609 [12], rs17820875 [12], and rs860713 [12]) were found
to influence adulthood BMI. The risk variants for adulthood BMI,
rs1121980,rs8050136, andrs9939609 [12],located between thefirst
two exons of FTO, had strong pairwise LD (r
2$0.85). Regional
Table 3. Significant Birth Weight6SNP and Age6SNP interactions.
Interaction
Age Range
(years)
Reference
Allele b1 b2 p-value q-value
Age6rs7138803 ,18 G 0.07 20.17 2.46*10
25 7.56*10
24
Age6rs2241423 $18 G 20.051 20.10 0.002 0.02
BW6rs6499640 ,18 G 20.91 20.04 0.008 0.037
BW6rs1121980 $18 T 20.88 21.75 0.009 0.043
BW: Birth Weight; b1: effect changes of heterozygous genotype for each one-year increase in age or one-kilogram increase in birth weight; b2: effect changes of
homozygous genotype of reference allele for each one-year increase in age or one-kilogram increase in birth weight.
doi:10.1371/journal.pone.0031470.t003
Figure 4. Percentage of cumulative BMI variance explained by sequentially added SNPs, shown from left to right, for (A) childhood
BMI and (B) adulthood BMI. Solid line: percentage of cumulative explained BMI variance. Dashed line: percentage of single-variant explained BMI
variance. The reference allele is indicated at the top of each column.
doi:10.1371/journal.pone.0031470.g004
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block between the upstream (25.46 cM/Mb) and downstream
recombination hotspots (67.32 cM/MB). In contrast, the other
three SNPs were located at or around the hotspot regions.
The interaction study showed that the longitudinal effects of
FAIM2 rs7138803 on childhood BMI and MAP2K5 rs2241423 on
adulthood BMI depend on age. The risk effects of the rs7138803
allele G (q-value=7.6*10
24, p-value=2.5*10
25) and the rs2241423
allele G (q-value=0.02, p-value=0.004) were significantly reduced
with increasing age. Both FAIM2 [28] and MAP2K5 [30] regulate
cell metabolism. The results indicate that age-dependent genetic
pathways related to cell apoptosis and proliferation can regulate
longitudinal BMI changes. This interaction study also showed that
effects of FTO rs6499640 on childhood BMI and rs1121980 on
adulthood BMI were associated with birth weight. There was a
significant negative association between birth weight and risk
genotype effect, and our findings indicate that low birth weight
increases the risk effect of rs6499640 GG and rs1121980 TT. Birth
weight is an indicator of intrauterine development of the fetus.
There is evidence that intrauterine development can influence the
risk of later onset obesity [3]. The findings of the present study
suggest that fetal nutrition can change the predisposition to obesity
by modifying these obesity-related gene effects.
SNPs in high LD and the tests of same variants with different
genetic models can all cause correlated results. To efficiently control
for correlated multiple tests, we selected the FDR method to
estimate the fraction of false positives among all tests (q-value). In
contrast to the false positive rate (p-value) a measure of the rate of
null associations deemed significant, the FDR cutoff point of
q=0.05 ensures that the error rate for findings deemed significant,
but that are actually false positives, is smaller than 5%. In this study,
both general and additive genetic models were used to examine the
longitudinal effects of candidate SNPs. This strategy will improve
the potential to identify inherited risk variants. For example, tests of
FTO variants (rs6499640, rs1121980, and rs8050136) based on the
general genetic model presented much stronger associations with
longitudinal BMI(q-value=1.8*10
24,0.03) than testsbased onthe
additive genetic model (q-value=0.07,0.10). Estimates of geno-
type effects based on the general model indicated that the pattern of
inheritance is closer to codominance (Figure 3).
Joint effects of multiple common variants at GWAS are often
estimated as a cumulatively additive effect for the number of risk
alleles, using weighted or unweighted methods [27,33,34]. However,
these methods generally require that all variants are independently
associated with risk [33]. In addition, because of allele heterogeneity,
the risk alleles may not be the same in different populations. We
therefore proposed the forward heuristic search method to identify
the best joint effectmodelandthe correspondingriskvariantsamong
the candidate variants. This method does not require mutual
independence of the candidate variants. It attempts to identify a list
of variants that are sequentially selected to make the best joint effect
model and to continuously improve prediction for target phenotype
based on minimization of AIC. In contrast to searching for SNPs
that have the largest effects at each step, the forward searching step
minimizing AIC has the advantage of maximally explaining BMI
variation by analyzing joint effects of multiple common variants and
confounding effects of non-genetic covariates together. For example,
in the best joint effect model search analysis of longitudinal
childhood BMI, rs2815752, the first selected SNP, explained a
much smaller percentage of BMI variance (9.0*10
26%) than
rs2241423, which explained the largest percentage of BMI variance
(0.90%). However, together with the three covariates, age, sex, and
birth weight,rs2815752bestpredictedthelongitudinalBMIwiththe
minimized AIC. The p-value for the best joint effect model is based
on a permutation test that also controls for potential correlation
among candidate variants.
Population structure and heterogeneity are critical issues in
causing false-positive associations. In this study, all subjects were
randomly selected from the white population living in the rural
community of Bogalusa, Louisiana. All 23 variants have frequencies
close to their frequencies in the HapMap white population (CEU)
and meet Hardy-Weinberg equilibrium. Allof the subjects had lived
in a small town and in the same neighborhood since childhood, and
environmental factors within the community were potentially
homogeneous [35,36]. Thus, confounding effects due to unknown
environment factors, genetic heterogeneity due to different
ethnicity, and false-positive associations due to biased selection
were reduced in this study. However, due to the restriction of
available data, we did not consider socioeconomic status, physical
activity, calorie intake, smoking, diabetes, hypertension, or family
history for their potential influences on this longitudinal genetic
study. Residual confounding due to these factors and the potential
existenceofunknown subpopulationstratification withinthestudied
white population may affect our findings. The influence of these
factors on the findings may require evaluation in follow-up studies.
In summary, we performed a longitudinal study to examine the
long-term effects of candidate SNPs that had been previously
reported as BMI-related risk variants in published GWAS. The
present study confirmed that risk variants of genes implicated in
pathways related to neural development and cell metabolism exert
major longitudinal effects on BMI. We also found that there are
different sets of risk variants associated with childhood and
adulthood BMI; that the effects of FAIM2 and MAP2K5, both
genes from a cell metabolism-related pathway, vary significantly
with age; that FTO influences both childhood and adulthood
BMI; that effects on obesity through appetite changes can be
modified during prenatal development; and that multiple variants
with weak or absent effects alone can jointly exert a large
longitudinal effect. These findings provide new insights into
biological processes influencing obesity development over the
course of childhood and adulthood, and will help to guide future
study of genetic pathways related to obesity development.
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